Stifel Financial
ABUS icon

Stifel Financial’s Arbutus Biopharma ABUS Stock Holding History

Stifel Financial’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-33,950
Closed -$443K – 2215
2014
Q2 		$443K Buy
+33,950
New +$481K ﹤0.01% 1564

Other funds holding ABUS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Stifel Financial's ABUS Position: Q3 2014 in Review

Stifel Financial sold out of Arbutus Biopharma (ABUS) in Q3 2014, closing a stake of 33,950 shares — an estimated $443K sold.

Stifel Financial first reported a position in ABUS in Q2 2014 and held it in 1 quarter. The position peaked at $443K in Q2 2014. 48 funds tracked by Wall St. Rank hold ABUS as of Q3 2014.

  • Stifel Financial reported no remaining Arbutus Biopharma position as of Q3 2014 after selling out during the quarter.
  • Stifel Financial sold 33,950 Arbutus Biopharma shares in Q3 2014, an estimated $443K.
  • Stifel Financial first reported a position in Arbutus Biopharma in Q2 2014 and held it in 1 quarter.
  • Stifel Financial's Arbutus Biopharma position peaked at $443K in Q2 2014.
  • 48 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2014.

Based on Stifel Financial's 13F filing for Q3 2014, filed 13 Nov 2014.